DX-9065a, a specific factor Xa inhibitor, as a universal anticoagulant for blood collection tubes

Clinica Chimica Acta

Volumn 294, Issue 1-2, 2000, Pages 27-35

  Kumura, Takeo ^a   Hino, Masayuki ^a   Yamane, Takahisa ^a   Tominaga, Keiko ^b   Tatsumi, Noriyuki ^a  

^a OSAKA CITY UNIVERSITY HOSPITAL   (Japan)

^b Osaka Prefecture University   (Japan)

Author keywords

Anticoagulant; Chemistry tests; DX 9065a; Ethylendiamine tetraacetic acid (EDTA); Hematology tests

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; CHOLINESTERASE; CYTOSOL AMINOPEPTIDASE; EDETIC ACID;

ARTICLE; BLOOD CELL COUNT; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL;

ANTICOAGULANTS; BLOOD CELL COUNT; BLOOD CHEMICAL ANALYSIS; BLOOD SPECIMEN COLLECTION; CHEMISTRY, CLINICAL; CHOLINESTERASES; DIAGNOSTIC TESTS, ROUTINE; EDETIC ACID; FACTOR XA; HUMANS; LEUCYL AMINOPEPTIDASE; NAPHTHALENES; PROPIONIC ACIDS; REGRESSION ANALYSIS;

OXY;

EID: 0034014961     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00185-6     Document Type: Article

References (13)

1. Katakura S., Nagahara T., Hara T., et al. A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin. Biochem Biophys Res Comm. 197:1997;965-972.
2. Hara T., Yokoyama A., Ishihara H., et al. DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa. Thromb Haemost. 71:1994;314-319.
3. Hara T., Yokoyama A., Morishima Y., et al. Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor. Thromb Res. 80:1995;99-104.
4. Hara T., Yokoyama A., Tanabe K., et al. DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats. Thromb Haemost. 74:1995;635-639.
5. Morishima Y., Tanabe K., Terada Y., et al. Antithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III dependent anticoagulants. Thromb Haemost. 78:1997;1366-1371.
6. Parasa D., Svendsen L., Sturzebecher J. Inhibition of thrombin generation in plasma by inhibitors of factor Xa. Thromb Haemost. 78:1997;1215-1220.
7. Vaz R.J., Mclean L.R., Pelton J.T. Evaluation of proposed of binding of (2S)-2-[4-[[(3S)-1-acetimidoyl-3-pyrrolidinyl]oxy]phenyl-3-[7-amidino-2- naphthyl]propanoic acid hydrochloride and some analogs to factor Xa using a comparative molecular field analysis. J Comput Aided Mol Des. 12:1998;99-110.
8. Kawai Y., Matsubayashi K. Photodecarboxylation of DX-9065a, new factor Xa inhibitor, in aqueous solution. Chem Pharm Bull. 46:1998;131-135.
9. Rao M.S., Olson A.J. Modelling of factor Xa-inhibitor complexes: a computational flexible docking approach. Proteins. 34:1999;173-183.
10. Herbert J.M., Bernat A., Dol F., et al. DX-9065a, a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies. J Pharmacol Exp Ther. 276:1996;1030-1038.
11. Murayama N., Tanaka S., Kikuchi T., et al. Radioimunoassay method for DX-9065a, an anticoagulant agent. Development, evaluation and application to human plasma. J Pharm Biomed Anal. 14:1996;1435-1445.
12. Kim D., Kambayashi J., Shibuya T., et al. In vivo evaluation of DX-9065a, a synthetic factor Xa inhibitor, in experimental vein graft. J Atheroscler Thromb. 2:1996;110-116.
13. Nakata M., Kanekura S., Maruyama I. DX-9065a, an Xa inhibitor, inhibits prothrombin-induced A549 lung adenocarcinoma cell proliferation. Cancer Lett. 122:1998;127-133.